Black Rock Inc. Deciphera Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.58 - $17.36 $244,575 - $312,653	18,010 Added 0.3%	5,994,276 $94.3 Million
Q4 2023 Feb 13, 2024	BUY	$10.11 - $16.54 $5.33 Million - $8.72 Million	527,260 Added 9.68%	5,976,266 $96.4 Million
Q3 2023 Nov 13, 2023	SELL	$12.46 - $15.48 $236,652 - $294,011	-18,993 Reduced 0.35%	5,449,006 $69.3 Million
Q2 2023 Aug 11, 2023	SELL	$13.28 - $15.96 $1.02 Million - $1.23 Million	-76,989 Reduced 1.39%	5,467,999 $77 Million
Q1 2023 May 12, 2023	BUY	$14.26 - $22.1 $1.78 Million - $2.76 Million	124,963 Added 2.31%	5,544,988 $85.7 Million
Q4 2022 Feb 13, 2023	BUY	$14.85 - $19.04 $3.09 Million - $3.96 Million	208,162 Added 3.99%	5,420,025 $88.8 Million
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $3.92 Million - $6.41 Million	-316,879 Reduced 5.73%	5,211,863 $96.4 Million
Q2 2022 Aug 12, 2022	BUY	$9.11 - $13.98 $6.23 Million - $9.55 Million	683,366 Added 14.1%	5,528,742 $72.7 Million
Q1 2022 May 12, 2022	BUY	$6.87 - $11.11 $7.2 Million - $11.6 Million	1,047,807 Added 27.59%	4,845,376 $44.9 Million
Q4 2021 Feb 10, 2022	BUY	$7.7 - $37.13 $790,512 - $3.81 Million	102,664 Added 2.78%	3,797,569 $37.1 Million
Q3 2021 Nov 09, 2021	BUY	$26.46 - $37.15 $362,290 - $508,657	13,692 Added 0.37%	3,694,905 $126 Million
Q2 2021 Aug 11, 2021	BUY	$32.73 - $47.95 $120 Million - $177 Million	3,681,213 New	3,681,213 $135 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.